Navigation path

Pharmaceuticals - Community Register


Community list of not active orphan medicinal products


Product information

Iodine (131I) chimeric IgG monoclonal antibody cG250

EU orphan designation number: EU/3/02/095
Active ingredient: Iodine (131I) chimeric IgG monoclonal antibody cG250
Indication: Treatment of renal cell carcinoma
Sponsor: Wilex AG
Grillparzerstraße 10, 81675 München, Deutschland

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
21/03/2002 Orphan designation EMEA/OD/053/01 (2002)1229 of 19/03/2002
01/09/2006 Change of name and/or address of sponsor
25/04/2014 Removal of orphan designation from Community Register